Drug Shortage Report for ATRIANCE
Report ID | 56126 |
Drug Identification Number | 02299925 |
Brand name | ATRIANCE |
Common or Proper name | ATRIANCE INJ 5MG/ML 50ML X 6 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | NELARABINE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 50ML X 6 |
ATC code | L01BB |
ATC description | ANTIMETABOLITES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-08-31 |
Actual start date | |
Estimated end date | 2018-09-04 |
Actual end date | 2018-08-28 |
Shortage status | Avoided shortage |
Updated date | 2018-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-08-28 | French | Compare |
v7 | 2018-08-28 | English | Compare |
v6 | 2018-08-28 | English | Compare |
v5 | 2018-08-16 | French | Compare |
v4 | 2018-08-16 | English | Compare |
v3 | 2018-08-16 | English | Compare |
v2 | 2018-07-20 | French | Compare |
v1 | 2018-07-20 | English | Compare |
Showing 1 to 8 of 8